Purpose of the development: To derive from the body of toxic substances.

Recommended application field: Special value of pharmaceuticals based Silix is that their use is indispensable in the aftermath of mass destruction as a result of natural population and man-made disasters. This includes above all the first aid for wounds, injuries, elimination and prevention of gastrointestinal infections, viral hepatitis, disinfection and purification of drinking water. Have promising use Silix integrated programs aimed at eliminating the long-term consequences of the Chernobyl disaster on the territory of Ukraine, Russia and Belarus.

Advantages over analogues: Physiological activity due Silix adsorbability to protein toxins, pathogens and viruses. Detoksitsiyny effect (~ 90%) is reached very quickly (5-10 min.). Use of the drug does not require a previous diagnosis of infection and enables to substantially reduce or eliminate the intake of antibiotics and other potent drugs which are generally toxic.

The development stage readiness: Introduced in production

Description of the development:
()
Characterized Silix significant sorption capacity with respect to proteins (up to 800 mg g of [-1]) and the bacteria (10 [8] - 10 [10] microbes per g [-1]), a wide range of the adsorption, a high adsorption rate.

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua